FILE PHOTO: Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with Reuters in Shanghai, China November 4, 2019. REUTERS/Brenda Goh/File Photo
LONDON (Reuters) - Glitches and delays in the manufacturing of coronavirus vaccines are inevitable given the speed at which they have been developed, AstraZeneca CEO Pascal Soriot told a news briefing on Friday.
Soriot said he would not comment on a dispute with the European Union over supplies, seeking to focus instead on the regulatory approval for the vaccine granted on Friday by the European Medicines Agency.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
